Shanghai Shyndec Pharmaceutical Co Ltd. Stock Analysis 600420.SS

Shanghai Shyndec Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, and sale of pharmaceutical products. The company is headquartered in Shanghai, Shanghai and currently employs 9,697 full-time employees. The company went IPO on 2004-06-16. The firm is mainly engaged in the research and development, production and sales of pharmaceutical intermediates and active pharmaceutical ingredients as well as drug preparations. The firm's products cover the therapeutic areas of systemic anti-infective, cardiovascular, anti-tumor and immunomodulators, central nervous system, hormones, urogenital system, digestive tract and metabolism, respiratory system and other fields. The firm is also engaged in animal vaccines, big health and other businesses, providing medical beauty products and skin care products. The firm distributes its products within the domestic market and to overseas markets.